EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 4.0

Establishment of epidemiological cut-off values for eravacycline, against Escherichia coli , Klebsiella pneumoniae , Enterobacter cloacae , Acinetobacter baumannii and Staphylococcus aureus

Ran Jing, Qiao-Lian Yi, Chao Zhuo, Wei Kang, Qi-Wen Yang iD, Yun-Song Yu, Bo Zheng, Yun Li, Fu-Pin Hu, Yang Yang, Jie Lin, Ge Zhang und 7 weitere

Journal of Antimicrobial Chemotherapy · 03.09.2024 · 79 (9) · 2246-2250

DOI: 10.1093/jac/dkae220 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 16.07.2024. Verfasst von Ran Jing und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy o…. Hauptthemen laut MEDLINE: Acinetobacter baumannii, Anti-Bacterial Agents, Microbial Sensitivity Tests, Tetracyclines. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National High Level Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To establish the epidemiology cut-off (ECOFF) values of eravacycline against Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, Acinetobacter baumannii and Staphylococcus aureus, from a multi-centre study in China.

Methods

We collected 2500 clinical isolates from five hospitals in China from 2017 to 2020. The MICs of eravacycline were determined using broth microdilution. The ECOFF values of eravacycline against the five species commonly causing cIAIs were calculated using visual estimation and ECOFFinder following the EUCAST guideline.

Results

The MICs of eravacycline against all the strains were in the range of 0.004–16 mg/L. The ECOFF values of eravacycline were 0.5 mg/L for E. coli, 2 mg/L for K. pneumonia and E. cloacae, and 0.25 mg/L for A. baumannii and S. aureus, consistent with the newest EUCAST publication of eravacycline ECOFF values for the populations. No discrepancy was found between the visually estimated and 99.00% ECOFF values calculated using ECOFFinder.

Conclusions

The determined ECOFF values of eravacycline against the five species can assist in distinguishing wild-type from non-wild-type strains. Given its promising activity, eravacycline may represent a member of the tetracycline class in treating cIAIs caused by commonly encountered Gram-negative and Gram-positive pathogens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acinetobacter baumanniiAnti-Bacterial AgentsMicrobial Sensitivity TestsTetracyclinesHumansChinaEnterobacter cloacaeEscherichia coliKlebsiella pneumoniaeStaphylococcus aureus

Substanzen

Anti-Bacterial AgentseravacyclineTetracyclines

Autor:innen und Institutionen

  • Department of Laboratory Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
  • Beijing Key Laboratory for Mechanisms Research and Precision Diagnosis of Invasive Fungal Diseases, Beijing, China.
  • Department of Clinical Infectious Diseases, The First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease, Guangzhou Medical University, Guangzhou, China.
  • Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, China.
  • Institute of Clinical Pharmacology, Peking University First Hospital, Beijing 100191, China.
  • Institute of Antibiotics, Huashan Hospital, Fudan University, and Key Laboratory of Clinical Pharmacology of Antibiotics, Shanghai, China.

ORCID-Profile: Qi-Wen Yang

Förderung

  • National High Level Hospital

Zitieren

APA

Jing, R., Yi, Q. L., Zhuo, C., Kang, W., Yang, Q. W., Yu, Y. S., Zheng, B., Li, Y., Hu, F. P., Yang, Y., Lin, J., Zhang, G., Zhang, J. J., Wang, T., Li, J., Zhuo, C. Y., Li, X., Zhu, Y. F., & Xu, Y. C. (2024). Establishment of epidemiological cut-off values for eravacycline, against Escherichia coli , Klebsiella pneumoniae , Enterobacter cloacae , Acinetobacter baumannii and Staphylococcus aureus. Journal of Antimicrobial Chemotherapy, 79(9), 2246-2250. https://doi.org/10.1093/jac/dkae220

Vancouver

Jing R, Yi QL, Zhuo C, Kang W, Yang QW, Yu YS, et al. Establishment of epidemiological cut-off values for eravacycline, against Escherichia coli , Klebsiella pneumoniae , Enterobacter cloacae , Acinetobacter baumannii and Staphylococcus aureus. Journal of Antimicrobial Chemotherapy. 2024;79(9):2246-2250. doi:10.1093/jac/dkae220

BibTeX
@article{Jing2024,
  author = {Jing, Ran and Yi, Qiao-Lian and Zhuo, Chao and Kang, Wei and Yang, Qi-Wen and Yu, Yun-Song and Zheng, Bo and Li, Yun and Hu, Fu-Pin and Yang, Yang and Lin, Jie and Zhang, Ge and Zhang, Jing-Jia and Wang, Tong and Li, Jin and Zhuo, Chu-Yue and Li, Xue and Zhu, Yun-Fan and Xu, Ying-Chun},
  title = {Establishment of epidemiological cut-off values for eravacycline, against Escherichia coli , Klebsiella pneumoniae , Enterobacter cloacae , Acinetobacter baumannii and Staphylococcus aureus},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2024},
  volume = {79},
  number = {9},
  pages = {2246--2250},
  doi = {10.1093/jac/dkae220}
}
Kostenlos starten →